Search company, investor...

Founded Year



Series A | Alive

Total Raised


About CirCode

CirCode develops a circular ribonucleic acid (RNA) technology platform to focus on the development of therapeutic drugs and vaccines. The company commits to bringing ribonucleic acid (mRNA) science to patients. It was founded in 2021 and is based in Pudong, China.

Headquarters Location

No. 8, Jiafeng Road, Waigaoqiao Free Trade Zone 9th Floor, Fudan Science and Technology Innovation Center

Pudong, Shanghai,




CirCode Frequently Asked Questions (FAQ)

  • When was CirCode founded?

    CirCode was founded in 2021.

  • Where is CirCode's headquarters?

    CirCode's headquarters is located at No. 8, Jiafeng Road, Waigaoqiao Free Trade Zone, Pudong.

  • What is CirCode's latest funding round?

    CirCode's latest funding round is Series A.

  • How much did CirCode raise?

    CirCode raised a total of $20M.

  • Who are the investors of CirCode?

    Investors of CirCode include Chaoxian Fund, Johnson & Johnson Innovation - JJDC, Kaitai Capital, EFung Capital, K2VC and 4 more.



CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.